Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Meloxicam and rizatriptan can eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity.

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

Iowa lawmakers just wrapped up their fourth week at the capitol and many bills are still making its way through subcommittees and committee.Double Up Food Buck ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

New Partnership for Africa’s Development (AUDA-NEPAD) and the Africa Centres for Disease Control and Prevention (Africa CDC) ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...